The CDK inhibitor p21Cip1/WAF1 is induced by FcγR activation and restricts the replication of human immunodeficiency virus type 1 and related primate lentiviruses in human macrophages

Journal of Virology

Volumn 83, Issue 23, 2009, Pages 12253-12265

  Bergamaschi, Anna ^a   David, Annie ^a   Le Rouzic, Erwann ^b,c   Nisole, Sébastien ^b,c   Barré Sinoussi, Françoise ^a   Pancino, Gianfranco ^a  

^a INSTITUT PASTEUR   (France)

^b INSTITUT COCHIN   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE INHIBITOR 1; FC RECEPTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; N (2 AMINOPHENYL) 4 (3 PYRIDINYLMETHOXYCARBONYLAMINOMETHYL)BENZAMIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN P21; SMALL INTERFERING RNA; VIRUS DNA; VIRUS PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOPRECIPITATION; LENTIVIRINAE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION; SIMIAN IMMUNODEFICIENCY VIRUS; TWO HYBRID SYSTEM; VIRUS REPLICATION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; GENE SILENCING; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 2; IMMUNOLOGY; PRIMATE; VIROLOGY; VIRUS DNA CELL DNA INTERACTION;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; PRIMATES; SIMIAN IMMUNODEFICIENCY VIRUS - MAC;

ANIMALS; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE KNOCKDOWN TECHNIQUES; HIV-1; HIV-2; HUMANS; LENTIVIRUSES, PRIMATE; MACROPHAGES; PRIMATES; RECEPTORS, IGG; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INTEGRATION; VIRUS REPLICATION;

EID: 70450193060     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01395-09     Document Type: Article

References (83)

1. WAF1 gene expression in human astrocytes. J. Biol. Chem. 279:46046-46056.
2. Aquaro, S., P. Bagnarelli, T. Guenci, A. De Luca, M. Clementi, E. Balestra, R. Caliò, and C. F. Perno. 2002. Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus. J. Med. Virol. 68:479-488.
3. Cip1/WAF1 in monocytic differentiation. EMBO J. 18:1223-1234.
4. Barr, S. D., J. R. Smiley, and F. D. Bushman. 2008. The interferon response inhibits HIV particle production by induction of TRIM22. PLoS Pathog. 4:e1000007.
5. Besson, A., S. F. Dowdy, and J. M. Roberts. 2008. CDK inhibitors: cell cycle regulators and beyond. Dev. Cell 14:159-169. (Pubitemid 351189186)
6. Bishop, K. N., M. Verma, E. Y. Kim, S. M. Wolinsky, and M. H. Malim. 2008. APOBEC3G inhibits elongation of HIV-1 reverse transcripts. PLoS Pathog. 4:e1000231.
7. Waf1/Cip1 Am. J. Biochem. Biotechnol. 2:33-40.
8. Bouazzaoui, A., M. Kreutz, V. Eisert, N. Dinauer, A. Heinzelmann, S. Hallenberger, J. Strayle, R. Walker, H. Rübsamen-Waigmann, R. Andreesen, and H. von Briesen. 2006. Stimulated trans-acting factor of 50 kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages. Virol. 356:79-94.
9. Brown, J. N., J. J. Kohler, C. R. Coberley, J. W. Sleasman, and M. M. Goodenow. 2008. HIV-1 activates macrophages independent of Toll-like receptors. PLoS ONE 3:e3664.
10. Brussel, A., and P. Sonigo. 2003. Analysis of early human immunodeficiency virus type 1 DNA synthesis by use of a new sensitive assay for quantifying integrated provirus. J. Virol. 77:10119-10124. (Pubitemid 37122094)
11. Chen, R., E. Le Rouzic, J. A. Kearney, L. M. Mansky, and S. Benichou. 2004. Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate the virus mutation rate and for replication in macrophages. J. Biol. Chem. 279:28419-28425.
12. Cherepanov, P., G. Maertens, P. Proost, B. Devreese, J. Van Beeumen, Y. Engelborghs, E. De Clercq, and Z. Debyser. 2003. HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J. Biol. Chem. 278:372-381.
13. Child, E. S., and D. J. Mann. 2006. The intricacies of p21 phosphorylation: protein-protein interactions, subcellular localization, and stability. Cell Cycle 5:1313-1319.
14. 2/M cell cycle arrest. Virology 305:371-377.
15. Waf1. J. Virol. 74:5040-5052.
16. Coqueret, O. 2003. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol. 13:65-70.
17. Cui, J., P. K. Tungaturthi, V. Ayyavoo, M. Ghafouri, H. Ariga, K. Khalili, A. Srinivasan, S. Amini, and B. E. Sawaya. 2006. The role of Vpr in the regulation of HIV-1 gene expression. Cell Cycle 5:2626-2638. (Pubitemid 44785807)
18. Kip1 in PMA-induced differentiation of HL60 cells. FEBS Lett. 472:50-52.
19. David, A., A. Saez-Cirion, P. Versmisse, O. Malbec, B. Iannascoli, F. Herschke, M. Lucas, F. Barre-Sinoussi, J. F. Mouscadet, M. Daeron, and G. Pancino. 2006. The engagement of activating FcγRs inhibits primate lentivirus replication in human macrophages. J. Immunol. 177:6291-6300. (Pubitemid 44628847)
20. el-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
21. Eng, E. W., J. Ibrahim, and R. E. Harrison. 2007. MTOC reorientation occurs during FcγR-mediated phagocytosis in macrophages. Mol. Biol. Cell 18:2389-2399.
22. Fassati, A., and S. P. Goff. 2001. Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. J. Virol. 75:3626-3635. (Pubitemid 32246372)
23. González-Scarano, F., and J. Martin-Garcia. 2005. The neuropathogenesis of AIDS. Nat. Rev. Immunol. 5:69-81.
24. Gorry, P. R., M. Churchill, S. M. Crowe, A. L. Cunningham, and D. Gabuzda. 2005. Pathogenesis of macrophage tropic HIV-1. Curr. HIV Res. 3:53-60.
25. Groot, F., S. Welsch, and Q. J. Sattentau. 2008. Efficient HIV-1 transmission from macrophages to T cells across transient virological synapses. Blood 111:4660-4663.
26. Gu, Y., C. W. Turck, and D. O. Morgan. 1993. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366:707-710. (Pubitemid 24036022)
27. Hamamoto, S., H. Nishitsuji, T. Amagasa, M. Kannagi, and T. Masuda. 2006. Identification of a novel human immunodeficiency virus type 1 integrase interactor, Gemin2, that facilitates efficient viral cDNA synthesis in vivo. J. Virol. 80:5670-5677. (Pubitemid 43849144)
28. Harper, J. W., N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816. (Pubitemid 23346377)
29. Herbein, G., A. Coaquette, D. Perez-Bercoff, and G. Pancino. 2002. Macrophage activation and HIV infection: can the Trojan horse turn into a fortress? Curr. Mol. Med. 2:723-738.
30. Holmes, R. K., K. N. Bishop, and M. H. Malim. 2007. APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation: comparisons with APOBEC3G. J. Biol. Chem. 282:2587-2595.
31. Iordanskiy, S., M. Altieri, F. Kashanchi, and M. Bukrinsky. 2006. Intracytoplasmic maturation of the human immunodeficiency virus type 1 reverse transcription complexes determines their capacity to integrate into chromatin. Retrovirology 3:4. (Pubitemid 43205339)
32. WAF1/CIP1 stability by WISp39, an Hsp90 binding TPR protein. Mol. Cell 17:237-249.
33. Joshi, T., J. P. Butchar, and S. Tridandapani. 2006. Fcγ receptor signaling in phagocytes. Int. J. Hematol. 84:210-216.
34. Kalpana, G. V., S. Marmon, W. Wang, G. R. Crabtree, and S. P. Goff. 1994. Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science 266:2002-2006.
35. Keedy, K. S., N. M. Archin, A. T. Gates, A. Espeseth, D. J. Hazuda, and D. M. Margolis. 2009. A limited group of class I histone deacetylases acts to repress human immunodeficiency virus type 1 expression. J. Virol. 83:4749-4756.
36. waf1/cip1 gene in apoptosis of HEp-2 treated with cisplatin or methotrexate. Cancer Gene Ther. 15:576-590.
37. Le Rouzic, E., N. Belaidouni, E. Estrabaud, M. Morel, J. C. Rain, C. Transy, and F. Margottin-Goguet. 2007. HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase. Cell Cycle 6:182-188. (Pubitemid 46232499)
38. Le Rouzic, E., A. Mousnier, C. Rustum, F. Stutz, E. Hallberg, C. Dargemont, and S. Benichou. 2002. Docking of HIV-1 Vpr to the nuclear envelope is mediated by the interaction with the nucleoporin hCG1. J. Biol. Chem. 277:45091-45098.
39. Lin, C. W., and A. Engelman. 2003. The barrier-to-autointegration factor is a component of functional human immunodeficiency virus type 1 preintegration complexes. J. Virol. 77:5030-5036. (Pubitemid 36402856)
40. Llano, M., D. T. Saenz, A. Meehan, P. Wongthida, M. Peretz, W. H. Walker, W. Teo, and E. M. Poeschla. 2006. An essential role for LEDGF/p75 in HIV integration. Science 314:461-464. (Pubitemid 44628966)
41. Luo, K., W. T., B. Liu, C. Tian, Z. Xiao, J. Kappes, and X. F. Yu. 2007. Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation. J. Virol. 81:7238-7248.
42. Mai, A., S. Massa, R. Pezzi, S. Simeoni, D. Rotili, A. Nebbioso, A. Scognamiglio, L. Altucci, P. Loidl, and G. Brosch. 2005. Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides. J. Med. Chem. 48:3344-3353.
43. Mangeat, B., G. Caron, M. Friedli, L. Perrin, and D. Trono. 2003. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424:99-103. (Pubitemid 36834849)
44. Marlow, L. A., L. A. Reynolds, A. S. Cleland, S. J. Cooper, M. L. Gumz, S. Kurakata, K. Fujiwara, Y. Zhang, T. Sebo, C. Grant, B. McIver, J. T. Wadsworth, D. C. Radisky, R. C. Smallridge, and J. A. Copland. 2009. Reactivation of suppressed RhoB is a critical step for the inhibition of anaplastic thyroid cancer growth. Cancer Res. 69:1536-1544.
45. Maroun, M., O. Delelis, G. Coadou, T. Bader, E. Segeral, G. Mbemba, C. Petit, P. Sonigo, J. C. Rain, J. F. Mouscadet, R. Benarous, and S. Emiliani. 2006. Inhibition of early steps of HIV-1 replication by SNF5/Ini1. J. Biol. Chem. 281:22736-22743.
46. Morisaki, H., A. Ando, Y. Nagata, O. Pereira-Smith, J. R. Smith, K. Ikeda, and M. Nakanishi. 1999. Complex mechanisms underlying impaired activation of Cdk4 and Cdk2 in replicative senescence: roles of p16, p21, and cyclin D1. Exp. Cell Res. 253:503-510.
47. Nebbioso, A., F. Manzo, M. Miceli, M. Conte, L. Manente, A. Baldi, A. De Luca, D. Rotili, S. Valente, A. Mai, A. Usiello, H. Gronemeyer, and L. Altucci. 2009. Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes. EMBO Rep. 10:776-782.
48. Orenstein, J. M., C. Fox, and S. M. Whal. 1997. Macrophages as a source of HIV during opportunistic infections. Science 276:1857-1861.
49. 2/M growth arrest and apoptosis after caspase-3 activation and bcl-2 phosphorylation in promonocytic U937 cells. Biochem. Biophys. Res. Commun. 286:726-734.
50. Peng, G., T. Greenwell-Wild, S. Nares, W. Jin, K. J. Lei, Z. G. Rangel, P. J. Munson, and S. M. Wahl. 2007. Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression. Blood 110:393-400. (Pubitemid 47026861)
51. Peng, G., K. J. Lei, W. Jin, T. Greenwell-Wild, and S. M. Wahl. 2006. Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity. J. Exp. Med. 203:41-46.
52. Perez-Bercoff, D., A. David, H. Sudry, F. Barre-Sinoussi, and G. Pancino. 2003. Fcγ-mediated suppression of human immunodeficiency virus type 1 replication in primary human macrophages. J. Virol. 77:4081-4094.
53. Reuse, S., M. Calao, K. Kabeya, A. Guiguen, J. S. Gatot, V. Quivy, C. Vanhulle, A. Lamine, D. Vaira, D. Demonte, V. Martinelli, E. Veithen, T. Cherrier, V. Avettand, S. Poutrel, J. Piette, Y. de Launoit, M. Moutschen, A. Burny, C. Rouzioux, S. De Wit, G. Herbein, O. Rohr, Y. Collette, O. Lambotte, N. Clumeck, and C. Van Lint. 2009. Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection. PLoS ONE 4:e6093.
54. CIP1/WAF1. Cancer Res. 63:3637-3645.
55. Saez-Cirion, A., M. A. Nicola, G. Pancino, and S. L. Shorte. 2006. Quantitative real-time analysis of HIV-1 gene expression dynamics in single living primary cells. Biotechnol. J. 1:682-689.
56. Saito, A., Y. Mariko, Y. Nosaka, K. Tsuchiya, T. Ando, T. Suzuki, T. Tsuruo, and O. Nakanishi. 1999. A synthetic inhibitor of histone deacetylase, MS- 27-275, with marked in vivo antitumor activity against human tumors. Proc. Natl. Acad. Sci. USA 96:4592-4597.
57. WAF1 expression in myeloid cells is activated by the protein kinase C pathway. Br. J. Cancer 76:1554-1557.
58. Schwartz, O., V. Marechal, B. Friguet, F. Arenzana-Seisdedos, and J. M. Heard. 1998. Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1. J. Virol. 72:3845-3850. (Pubitemid 28188684)
59. Selig, L., J. C. Pages, V. Tanchou, S. Prévéral, C. Berlioz-Torrent, L. X. Liu, L. Erdtmann, J. Darlix, R. Benarous, and S. Benichou. 1999. Interaction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses. J. Virol. 73:592-600.
60. Sharova, N., M. Sharkey, and M. Stevenson. 2005. Macrophages archive HIv-1 virions for dissemination in trans. EMBO J. 24:2481-2489.
61. Skolnik, P. R., J. M. Mathys, and A. S. Greenberg. 2002. Stimulation of peroxisome proliferator-activated receptors alpha and gamma blocks HIV-1 replication and TNFα production in acutely infected primary blood cells, chronically infected U1 cells, and alveolar macrophages from HIV-infected subjects. J. Acquir. Immune Defic. Syndr. 33:1-10.
62. WAF1 prevents down-modulation of the apoptotic inhibitor protein c-IAP1 and inhibits leukemic apoptosis. Mol. Med. 6:736-749.
63. Stremlau, M., M. J. Perron, M. Kiessling, P. Autissier, and J. Sodroski. 2004. The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys. Nature 427:848-853. (Pubitemid 38297747)
64. Sung, T. L., and A. P. Rice. 2009. miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1. PLoS Pathog. 5:e1000263.
65. Takeuchi, H., and T. Matano. 2008. Host factors involved in resistance to retroviral infection. Microbiol. Immunol. 52:318-325.
66. Tanaka, T., K. S. Suh, A. M. Lo, and L. M. De Luca. 2007. p21WAF1/CIP1 is a common transcriptional target of retinoid receptors: pleiotropic regulatory mechanism through retinoic acid receptor (RAR)/retinoid X receptor (RXR) heterodimer and RXR/RXR homodimer. J. Biol. Chem. 282:29987-29997.
67. Uchil, P. D., B. D. Quinlan, W. T. Chan, J. M. Luna, and W. Mothes. 2008. TRIM E3 ligases interfere with early and late stages of the retroviral life cycle. PLoS Pathog. 4:e16.
68. Vandekerckhove, L., B. Van Maele, J. De Rijck, R. Gijsbers, C. Van den Haute, M. Witvrouw, and Z. Debyser. 2006. Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus. J. Virol. 80:1886-1896. (Pubitemid 43228728)
69. Vázquez, N., T. Greenwell-Wild, N. J. Marinos, W. D. Swaim, S. Nares, D. E. Ott, U. Schubert, P. Henklein, J. M. Orenstein, M. B. Sporn, and S. M. Wahl. 2005. Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation. J. Virol. 79:4479-4491.
70. Verani, A., G. Gras, and G. Pancino. 2005. Macrophages and HIV-1: dangerous liaisons. Mol. Immunol. 42:195-212.
71. Wang, X., W. Hou, Y. Zhou, Y. J. Wang, D. S. Metzger, and W. Z. Ho. 2009. Cellular microRNA expression correlates with susceptibility of monocytes/ macrophages to HIV-1 infection. Blood 113:671-674.
72. WAF1 and proliferating cell nuclear antigen. Curr. Biol. 5:275-282.
73. Wei, B. L., P. W. Denton, E. O'Neill, T. Luo, J. L. Foster, and J. V. Garcia. 2005. Inhibition of lysosome and proteasome function enhances human immunodeficiency virus type 1 infection. J. Virol. 79:5705-5712.
74. Weiden, M., Y. Qiao, B. Y. Zhao, Y. Honda, K. Nakata, A. Canova, D. E. Levy, W. N. Rom, and R. Pine. 2000. Differentiation of monocytes to macrophages switches the Mycobacterium tuberculosis effect on HIV-1 replication from stimulation to inhibition: modulation of interferon response and CCAAT/enhancer binding protein beta expression. J. Immunol. 165:2028-2039.
75. Wu, W., K. Kehn-Hall, C. Pedati, L. Zweier, I. Castro, Z. Klase, C. S. Dowd, L. Dubrovsky, M. Bukrinsky, and F. Kashanchi. 2008. Drug 9AA reactivates p21/Waf1 and Inhibits HIV-1 progeny formation. Virol. J. 5:41. (Pubitemid 351550364)
76. Xaus, J., A. F. Valledor, C. Soler, J. Lloberas, and A. Celada. 1999. Interferon gamma induces the expression of p21waf-1 and arrests macrophage cell cycle, preventing induction of apoptosis. Immunity 11:103-113. (Pubitemid 29359961)
77. Xiong, Y., H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704. (Pubitemid 24036020)
78. Yamamoto, N., Y. Wu, M. O. Chang, Y. Inagaki, Y. Saito, T. Naito, H. Ogasawara, I. Sekigawa, and Y. Hayashida. 2006. Analysis of human immunodeficiency virus type 1 integration by using a specific, sensitive and quantitative assay based on real-time polymerase chain reaction. Virus Genes 32:105-113. (Pubitemid 43357616)
79. Yoder, K., A. Sarasin, K. Kraemer, M. McIlhatton, F. Bushman, and R. Fishel. 2006. The DNA repair genes XPB and XPD defend cells from retroviral infection. Proc. Natl. Acad. Sci. USA 103:4622-4627.
80. Waf1/Cip1/Sdi1 expression increases gene transduction efficiency in primitive human hematopoietic cells. Gene Ther. 12:1444-1452.
81. Waf1/Cip1/Sdi1. J. Clin. Investig. 117:473-481.
82. Waf1/Cip1. Mol. Cell. Biol. 26:2782-2790.
83. Zybarth, G., H. Schmidtmayerova, B. Sherry, and M. Bukrinsky. 1999. Activation-induced resistance of human macrophages to HIV-1 infection in vitro. J. Immunol. 162:400-406. (Pubitemid 29018947)